SightfileU.S. market data from official filings

Companies › ELAN

ELANCO ANIMAL HEALTH INC (ELAN)

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001739104 · EDGAR filings · Updated 2026-07-28

ELANCO ANIMAL HEALTH INC (ELAN) has reported institutional ownership of 109.2%, with 513 institutional managers holding positions valued at $13.0B per the latest 13F reporting period. SEC filings include an active material impairment disclosure (8-K Item 2.06).

Institutional ownership
109.2%
Institutional managers
513
Reported 13F value
$13.0B
Insider activity
60 trans.
$937.9K net buying
Data flags
1 active
from SEC filings

Filings this week (3)

Every filing links to the official SEC document. Real-time filing alerts for this company are available inside the app.

Latest updates

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, ELANCO ANIMAL HEALTH INC has 513 institutional holders and institutional ownership of 109.2%.

Insider activity

Insiders reported 60 transactions (4 buys, 0 sells) across 21 reporting insiders, with a net reported value of $937.9K.

Data flags from SEC filings

Active material impairment disclosure (8-K Item 2.06), most recently filed 2021-06-09 (recurring since 2021-06-09) — source filing. The authoritative details are those stated in the filing itself.

Related companies

BRIDGEBIO PHARMA INC (BBIO) · VIATRIS INC (VTRS) · NEUROCRINE BIOSCIENCES INC (NBIX) · IONIS PHARMACEUTICALS INC (IONS) · GUARDANT HEALTH INC (GH) · ASCENDIS PHARMA A/S SPONSORED (ASND)

See full history, cross-references and alerts on Sightfile
Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-07-28.